A study conducted by researchers at The University of Texas MD Anderson Cancer Center demonstrated acceptable toxicity and anti-tumor activity
Pembrolizumab shows promise for some advanced, hard-to-treat rare cancers

besthealthtale.com
Home ยป
A study conducted by researchers at The University of Texas MD Anderson Cancer Center demonstrated acceptable toxicity and anti-tumor activity
THURSDAY, Dec. 20, 2018 — For patients with recurrent or metastatic head and neck squamous cell carcinoma, pembrolizumab has a